Mabion SA (DE:272)

FRANKFURT:272

272

Mabion SA

RESEARCH TOOLSreports

Compare Mabion SA (272) vs. Competitors

0 Followers

Comparison Results

272

Mabion SA

€1.85

€32.41M

-3.23

-13.05%

―

Ryvu Therapeutics SA

zł27.65

zł529.45M

-6.19

-11.92%

―

Scope Fluidics SA

zł139.00

zł440.39M

-9.31

-29.37%

―

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

zł3.68

zł278.84M

-10.03

-20.17%

―

Captor Therapeutics SA

zł42.20

zł448.71M

-4.87

103.02%

―

OncoArendi Therapeutics SA

zł5.28

zł108.78M

-8.61

-43.23%

―

xxxxxxxxxxxxx

272 vs MOC

xxxxxxxxxxxxx

Performance Comparison

DE:272

Mabion SA

1.98

-0.02

-1.10%

PL:RVU

Ryvu Therapeutics SA

22.90

0.30

1.33%

PL:SCP

Scope Fluidics SA

139.00

-40.60

-22.61%

PL:SVE

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

3.68

-0.64

-14.81%

PL:CTX

Captor Therapeutics SA

80.80

46.30

134.20%

PL:MOC

OncoArendi Therapeutics SA

5.28

-3.18

-37.59%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >